MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation Operating Expenses 2011-2026 | BSX
Annual Operating Expenses Boston Scientific Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.2 B | 8.89 B | 7.55 B | 7.08 B | 6.98 B | 6.53 B | 5.88 B | 5.35 B | 4.92 B | 4.64 B | 4.31 B | 4.27 B | 4.08 B | 3.97 B | 3.24 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.2 B | 3.24 B | 5.86 B |
Quarterly Operating Expenses Boston Scientific Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.49 B | 2.6 B | 2.29 B | 2.16 B | 2.33 B | 1.97 B | 1.73 B | 2.03 B | 1.8 B | - | 1.83 B | 1.81 B | 1.6 B | - | 1.64 B | 1.87 B | 1.49 B | - | 2 B | 1.28 B | 1.59 B | - | 1.55 B | 1.49 B | 1.22 B | - | 1.33 B | 1.36 B | 1.3 B | - | 1.21 B | 1.4 B | 1.15 B | - | 1.16 B | 1.82 B | 1.1 B | - | 1.65 B | 1.08 B | 1.22 B | - | 1.23 B | 1.38 B | 1.04 B | - | 1.12 B | 1.06 B | 1.51 B | - | 1.77 B | 4.84 B | 1.04 B | - | 1.02 B | 1.05 B | 972 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.84 B | 972 M | 1.61 B |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 8.99 | -4.16 % | $ 255 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.45 | -0.29 % | $ 129 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.01 | -0.5 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.6 | - | $ 122 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 36.14 | -1.65 % | $ 5.38 K | USA |
 |
Globus Medical
GMED
|
547 M | $ 90.07 | 1.66 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.78 | -6.32 % | $ 1.08 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 9.27 | -0.43 % | $ 714 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 54.06 | -0.15 % | $ 1.59 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.01 | 1.34 % | $ 17.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 85.48 | -0.18 % | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.68 | -1.63 % | $ 368 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.83 | -1.1 % | $ 69.7 M | USA |
 |
Medtronic PLC
MDT
|
15.3 B | $ 86.15 | -0.15 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.66 | -5.68 % | $ 27.6 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 166.53 | -3.11 % | $ 12.5 B | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 11.68 | -0.76 % | $ 463 M |  Curacao |
 |
AxoGen
AXGN
|
121 M | $ 30.86 | -5.45 % | $ 1.42 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
753 M | $ 329.86 | - | $ 12.8 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Insulet Corporation
PODD
|
531 M | $ 202.45 | -0.52 % | $ 14.2 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.53 | - | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.03 | -2.54 % | $ 853 M | USA |
 |
Smith & Nephew plc
SNN
|
2.67 B | $ 31.63 | -3.06 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 330.34 | -0.59 % | $ 126 B | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.59 | 0.76 % | $ 36.7 M | USA |
 |
Tactile Systems Technology
TCMD
|
221 M | $ 24.31 | -1.06 % | $ 556 M | USA |
 |
TELA Bio
TELA
|
88.1 M | $ 0.67 | 6.38 % | $ 31.5 M | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 106.65 | 1.77 % | $ 3.63 B | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 19.31 | 0.74 % | $ 1.31 B | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 9.64 | -0.67 % | $ 345 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |